| ATPC 0.1157 65.29% | MTEN 0.0323 -8.50% | OCG 0.0098 -16.95% | SOXS 2.065 -9.43% | AUID 2.295 131.23% | CJMB 5.0131 347.60% | IVP 0.0477 -41.83% | ZSL 2.9499 4.61% | SLV 82.9899 -1.86% | NVDA 187.4686 2.36% | SPHL 16.5703 636.46% | INTC 49.117 0.81% | APLT 0.1014 1.50% | BNKK 4.34 56.12% | DVLT 0.7402 3.06% | SOXL 60.9973 10.14% | TQQQ 55.57 3.23% | ASST 0.9927 -3.62% | BYND 1.02 6.04% | TZA 5.905 -4.14% | GRAB 4.41 -4.75% | TSLL 18.3793 1.71% | EEM 58.31 0.97% | ONDS 13.055 -3.72% | BBAI 6.375 1.84% | TSLS 5.145 -0.87% | SPY 694.78 0.64% | IBRX 3.6479 20.79% | MSTX 4.96 -4.62% | NOK 6.725 5.74% | DUST 5.775 -0.43% | AMD 236.295 5.68% | SIDU 3.595 -4.13% | RZLV 4.69 15.52% | BITO 13.39 -1.25% | IBIT 54.725 -1.29% | JTAI 0.4753 4.55% | AAL 15.765 4.13% | NVD 7.065 -4.66% | VALE 14.755 0.99% | QQQ 626.2588 1.08% | PLUG 2.34 -0.43% | SQQQ 64.7999 -3.20% | TSM 349.625 6.88% | XLF 54.585 0.80% | TSLA 443.0155 0.87% | CRWV 98.9301 10.17% | SEGG 1.0905 17.68% | CAN 0.8098 -7.46% | PTHL 0.5285 20.17%

Pfizer Raises Profit Forecast After Q2 Earnings Beat

Pfizer (NYSE:PFE) posted better-than-expected second-quarter earnings and revenue and raised its full-year profit outlook, sending shares up over 4% intra-day.

The pharmaceutical giant reported earnings per share of $0.78 for the quarter, ahead of the $0.57 consensus. Revenue rose 10% year-over-year to $14.7 billion, also topping estimates of $13.47 billion.

Chairman and CEO Dr. Albert Bourla said the quarter reflected strong execution, commercial progress, and pipeline advancement. The company cited margin improvement, lower tax rates, and favorable currency moves as drivers of the revised forecast.

Pfizer raised its full-year adjusted EPS guidance to a range of $2.90–$3.10, up $0.10 at the midpoint. The company maintained its full-year revenue forecast of $61.0 billion to $64.0 billion.

Published on: August 5, 2025